> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Novo Nordisk’s Insulin Icodec
- URL: https://www.fdaweb.com/panel-to-review-novo-nordisks-insulin-icodec/
- Published: 2024-04-29T12:00:00.000Z
- Updated: 2026-09-14T14:29:28.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5156868

*Federal Register* notice: FDA schedules a 5/24 Endocrinologic and Metabolic Drugs Advisory Committee meeting to discuss the safety and efficacy of a Novo Nordisk BLA for NNC0148–0287 for injection (insulin icodec), a long-acting insulin analog product. The proposed indication is to improve glycemic control in adults with diabetes mellitus. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-04-29/pdf/2024-09158.pdf?ref=fdaweb.com).